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Division of Molecular Medicine, Bose Institute, Kolkata, India
Silymarin (SMN) has been shown to possess a wide range of biological and
pharmacological effects. Besides, SMN has antioxidant and free radical scavenging
activities. Thioacetamide (TAA) is a well-documented liver toxin that requires oxidative
bioactivation to elicit its hepatotoxic effect which ultimately modifies amine-lipids and
proteins. Our study has been designed in a TAA exposed mouse model to investigate
whether SMN could protect TAA-induced oxidative stress mediated hepatic and renal
damage. Results suggest that TAA generated reactive oxygen species (ROS), caused
oxidative stress and induced apoptosis in the liver and kidney cells via JNK as well
as PKC and MAPKs signaling. All these detrimental effects of TAA could, however,
be suppressed by SMN which not only scavenged ROS but also induced PI3K-Akt
cell survival pathway in the liver and prevented apoptotic pathways in both the organs.
Histological studies, collagen staining and DNA fragmentation analysis also supported
our results. Combining, we say that SMN possess beneficial role against TAA mediated
hepatic and renal pathophysiology.
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INTRODUCTION
Silymarin (SMN), an extract of Silybum marianum, has well-known hepatoprotective properties
(Letteron et al., 1990; Muriel and Mourelle, 1990a). Being a standardized mixture of
flavonolignans, including silibinin, silydianin, sosilibinin, and silychristin, SMN shows free
radical scavenging property and cell membrane stabilizing activity (Muriel and Mourelle,
1990a,b; Abdel-Moneim et al., 2015; Reina and Martinez, 2016). At the molecular level, it
is believed that SMN stimulates RNA and protein synthesis leading to faster regeneration of
damaged liver tissue. SMN also modulates TNF-α associated inflammation pathway. However,
the vivid molecular pathways through which SMN exerts its effects are still not clear.
The present study has been aimed to investigate the effects of SMN during thioacetamide
(TAA) induced hepatotoxicity in details. TAA is used as a fungicide and also serves as a
source of sulfur in industries and pharmaceuticals (Kadir et al., 2011). Most importantly, it
Abbreviations: ALP, alkaline phosphatase; ALT, alanine transaminase; AST, aspartate transaminase; CAT, catalase; GPx,
glutathione peroxidase; GR, glutathione reductase; GST, glutathione S-transferase; LDH, lactate dehydrogenase; PARP, poly
(ADP-ribose) polymerase 1; ROS, reactive oxygen species; SOD, superoxide dismutase.
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is a typical hepatotoxin that dose dependently causes
centrilobular cell death accompanied by enhanced plasma
transaminases and bilirubin. It has been observed that acute
exposure with TAA causes necrosis while chronic exposure
causes apoptosis in the liver (Moreira et al., 1995). To elicit these
effects, TAA requires oxidative bioactivation into its S-oxide
(TASO) ultimately leading to its chemically reactive S,S-dioxide
(TASO2) form (Hajovsky et al., 2012). These metabolites are then
distributed among several organs including plasma, liver, kidney,
adrenals, bone marrow, and other tissues (Barker and Smuckler,
1974) and modify amine-lipids along with proteins leading to
further systemic oxidative stress.
Liver plays a crucial role in the metabolic elimination of most
of the currently used drugs and many other foreign compounds,
thereby making it one of the most viable target organs for toxicity.
Therefore, hepatoprotective agents are necessary in clinical
therapy to fight against increasing liver toxic injury (Sinha et al.,
2007b). Moreover, vast knowledge of the underlying mechanism
of hepatotoxicity has to be attained. Unfortunately, necessary
studies, in this field, are limited because of the lack of satisfactory
experimental models. Nevertheless, some chemical toxins (like
carbon tetrachloride, acetaminophen, and TAA) are often used
to create experimental hepatocyte injury models in both in vivo
and in vitro conditions (Ledda-Columbano et al., 1991; Kucera
et al., 2006; Domenicali et al., 2009; Rousar et al., 2009). However,
detail mechanism was not investigated thoroughly. Therefore,
in the present study, we have taken a detailed mechanistic
approach to explore the molecular signaling pathways as well as
histopathological examinations to find out how SMN exerts its
beneficial effects. It is to be mentioned that, we have also observed
renal dysfunctions with the exposure of TAA and investigated this
renal toxicity too in details. For this purpose, the protective action
of SMN was evaluated on the basis of several parameters like the
activity of antioxidant enzymes and cellular antioxidant power
(FRAP); increase of the body weight and cellular non-enzymatic
antioxidant (GSH) content; amelioration of the tissue damage
(histological assessment) and most importantly the interaction of
different signaling molecules associated with the ameliorative role
of SMN.
MATERIALS AND METHODS
Materials
Chemicals
Silymarin, TAA, BSA, Bradford reagent, anti-Bcl-2, anti- Bcl-xL,
anti-Bad, and anti-Bax antibodies were purchased from Abcam
(UK). Other antibodies were purchased from Sigma-Aldrich
Chemical Company (St. Louis, MO, USA). Kits for measurement
of blood glucose and LDH were purchased from Span Diagnostic
Ltd., India. All other chemicals were bought from Sisco Research
Laboratory, India.
Animals
Adequate numbers of adult male Swiss Albino mice weighing
∼20–25 g were acclimatized under laboratory conditions for
2 weeks before any experiment. Animals were maintained under
standard conditions of temperature (23 ± 2◦C) and humidity
(50 ± 10%) with alternating 12 h light/dark cycle. The animals
were given free access to water and fed standard pellet diet
(Agro Corporation Private Ltd., Bangalore, India). All the
experiments that had been conducted with animals followed the
guidelines approved by the IAEC (Institutional Animal Ethical
Committee), Bose Institute, Kolkata [IAEC/BI/3(I) cert./2010]
and the study had been approved by both CPCSEA (Committee
for the Purpose of Control & Supervision on Experiments on
Animals) Ministry of Environment and Forests, New Delhi, India
(1796/PO/Ere/S/14/CPCSEA) and IAEC.
Methods
Experimental Design for in vivo Treatments
To design the in vivo experimental study the mice were randomly
assigned to four groups and treated as follows:
Group 1: Normal group: mice received neither TAA nor SMN,
received vehicle only.
Group 2: Silymarin group: mice received only SMN
(150 mg/kg body weight in olive oil) orally for 8 weeks
(simultaneously with Group 4).
Group 3: Thioacetamide group: mice received TAA injection
at a dose of 100 mg/Kg body weight twice a week for 56 days
(Ansil et al., 2011).
Group 4: TAA and SMN group (post-treatment group): mice
received SMN (150 mg/kg body weight in olive oil) orally for
8 weeks after TAA administration twice a week for 56 days.
After the experimental periods animals were sacrificed by
cervical dislocation and livers and kidneys were collected.
Determination of Dose and Time-Dependent Activity
of SMN by ALP Assay
For this study, mice were randomly distributed into seven groups
each consisting of six animals. The first two groups served
as normal control (receiving vehicle only) and toxin control
(receiving TAA at a dose of 100 mg/kg body weight thrice a week
in citrate buffer, pH 4.5, i.p.), respectively. The remaining five
groups of animals were treated with five different doses of SMN
(50, 100, 150, 200, and 250 mg/kg body weight) for 56 days after
3 weeks followed by TAA administration (Figure 1A).
For the time-dependent study, mice were randomly
distributed into six groups each consisting of six animals.
The first group served as normal control receiving only vehicle
and the second group served as toxin control exposed to TAA at
a single dose of 100 mg/kg body weight thrice a week in citrate
buffer, pH 4.5, i.p. The remaining four groups of animals were
treated with SMN orally at a dose of 150 mg/kg body weight, once
daily for 2, 4, 8, and 12 weeks after the last TAA administration
(Figure 1B).
Measurement of Body Weight
The body weights of all the experimental animals from each
group were measured.
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FIGURE 1 | (A) Representation of the dose dependent study of SMN on ALP level in TAA-treated pathophysiology in the serum of the experimental mice. Cont:
measurement of serum ALP in normal mice, TAA: measurement of serum ALP in TAA administered mice, TAA+SMN 50, TAA+SMN 100, TAA+SMN 150,
TAA+SMN 200, and TAA+SMN 250: measurement of serum ALP in mice which are treated with SMN at a dose of 50, 100, 150, 200, and 250 mg/kg body weight,
orally, respectively, after TAA administration at a dose of 100 mg/kg body weight, i.p. (B) Representation of the time dependent study of SMN on ALP activity in
TAA-exposed pathophysiology in the serum of the experimental mice. Cont: measurement of serum ALP in normal mice, TAA: measurement of serum ALP in TAA
exposed mice, TAA+SMN 2 week, TAA+SMN 4 week, TAA+SMN 8 week, and TAA+SMN 12 week: measurement of serum ALP in mice which are treated with
SMN at a dose of 150 mg/kg body weight, orally for 2, 4, 8, 12, and 16 weeks, respectively. “a” indicates the significant difference between the normal control and
TAA exposed groups, “b” indicates the significant difference between TAA exposed (toxin control) and SMN post-treated groups. Each column represents
mean ± SEM, n = 6; (pa < 0.05, pb < 0.05).
Preparation of Liver Tissue Homogenate
Liver tissues from experimental animals were first homogenized
(1:4, w/v) in ice-cold 0.1 M phosphate buffer (pH 7.4) containing
2 mM EDTA. The homogenate was later centrifuged at
10,000 × g for 30 min at 4◦C. The supernatant was collected and
recentrifuged at 105,000 × g for 55 min. The subsequent pellets
containing microsomal fractions were suspended in 0.25 mM
sucrose solution containing 1 mM EDTA and stored at −80◦C
until further use. The resulting supernatant containing the
cytosolic fraction was also collected and used for the experiments.
The protein contents of both the cytosolic and microsomal
fractions were estimated by the method of Bradford (1976) using
crystalline BSA as standard.
Determination of Hepatic and Renal Markers and
Nitric Oxide Production
Specific markers associated with hepatic and renal dysfunction,
e.g., AST, ALT, ALP activities, BUN, creatinine, and albumin were
estimated by using standard kits. LDH activity was estimated
according to the method of Kornberg (1955). The hepatic nitric
oxide (NO) level was indirectly assessed using the Griess reaction
(Green et al., 1982; Suresh and Das, 2006).
Estimation of Lipid Peroxidation
Lipid peroxidation in terms of malondialdehyde (MDA)
formation was estimated following the method of Esterbauer and
Cheeseman (1990).
Assay of Cellular Metabolites
GSH content was measured, according to the method of Ellman
(1959).
GSSG content was estimated following the method of Hissin
and Hilf (1976).
Determination of in vivo Antioxidant Power by FRAP
Assay
Ferric Reducing Antioxidant Power assay was performed
following the method as described by Benzie and Strain (1999).
Assay of Antioxidant Enzymes
Activities of different antioxidant enzymes (SOD, CAT, GST, GR,
and GPx) have been assessed using the liver tissue homogenates.
SOD activity was evaluated as described previously (Manna et al.,
2013). One unit of SOD activity could be defined as the enzyme
concentration that required to attenuate chromogen production
by 50% in 1 min under the assay conditions.
Catalase activity was estimated by following the
decomposition of H2O2 at 240 nm for 10 min according to
the method of Bonaventura et al. (1972). One unit of CAT
activity is defined as the amount of enzyme, which reduces one
µmol of H2O2 per minute.
Glutathione S-transferase activity was assayed based on
the conjugation reaction with GSH in the primary step of
mercapturic acid synthesis (Habig et al., 1974). GST activity
was expressed as µmoles of CDNB conjugate formed/min/mg
protein.
Glutathione reductase activity was determined following the
method of Smith et al. (1988).
Glutathione peroxidase activity was measured according to
the method of Flohé and Günzler (1984) using H2O2 and
NADPH as substrates.
Determination of Radical-Scavenger Activity of SMN
in a Cell-Free System
Superoxide radical-scavenging activity
The superoxide radical-scavenging activity of SMN was measured
according to the method of Siddhuraju and Becker (2003) and
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Ghosh et al. (2010). Briefly, the reaction mixture contained 0.1
M phosphate buffer, pH 7.4, 50 µM nitro blue tetrazolium,
468 µM NADH, 60 µM phenazine methosulfate, and different
concentrations of SMN. The mixture was then incubated in the
dark for 10 min at room temperature and the absorbance was
read at 560 nm. Results were expressed as percentage inhibition.
All experiments were performed in triplicate.
Hydroxyl radical-scavenging activity
The hydroxyl radical-scavenging activity of SMN was measured
according to the method of Nash (1953). Briefly, hydroxyl
radicals content was measured by the amount of formaldehyde
(detected spectrophotometrically at 412 nm) produced from the
oxidation of dimethyl sulfoxide (DMSO). All experiments were
performed in triplicate.
Nitric oxide radical-scavenging activity
The nitric oxide radical-scavenging activity of SMN was
determined according to the method of Green et al. (1982).
The amount of the chromophore formed was detected
spectrophotometrically at 540 nm. Results were expressed
as percentage. All experiments were performed in triplicates.
DNA Fragmentation Assay
DNA fragmentation assay was performed following the method
of Das and Sil (2012).
Determination of Mitochondrial Membrane Potential
(1ψm )
Mitochondria were isolated following the method of Hodârnâu
et al. (1973). In short, the membrane potential (1ψm ) was
measured using a FACS machine with an argon laser excitation
at 488 and 525 nm band pass filter. The evaluation of the
mitochondrial membrane potential (1ψm ) was determined on the
basis of cell preservation of the fluorescent probe JC-1.
Immunoblotting
Proteins (50 µg) from each sample were separated by 10%
SDS-PAGE and transferred into PVDF membranes. Membranes
were then blocked using BSA and incubated separately with
primary antibodies of anti caspase-3, anti- PARP, and anti-Bcl-xL
(1:1000 dilution), anti cytochrome c (1:1000 dilution), anti Bad
(1:1000 dilution), anti Bax (1:1000 dilution), anti Bcl-2 (1:1000
dilution), etc., at 4◦C for overnight. All the primary antibodies
were detected against HRP-conjugated secondary antibody using
the HRP substrate ECL solution (Sarkar et al., 2016).
Measurement of Hepatic Collagen Content
Hepatic collagen content was estimated following the method of
Gascon-Barré et al. (1989). Briefly, liver sections (15 µm thick)
were taken from liver blocks embedded in paraffin and then
deparaffinised producing tissue areas of ∼50–100 mm2. These
were then incubated in 0.04% (w/v) solution of fast green in
saturated picric acid for about 15 min. After that, all the sections
were washed with distilled water, incubated with fast green FCF
0.1% (w/v) and sirius red F3B 0.04% (w/v) for about 30 min, then
washed again with distilled water until the eluted fluid becomes
completely colorless. Then 1 ml of 0.05 N NaOH in 50% (v/v)
aqueous methanol was added in each tube and mixed gently. The
eluted color was quantified by the help of a spectrophotometer
at two wavelengths viz. 530 and 605 nm (corresponding to the
absorbance maxima of sirius red and fast green, respectively).
Isolation of Primary Mouse Hepatocytes
Hepatocytes were isolated from mice liver by the perfusion
technique with collagenase type I at 37◦C (Sinha et al., 2007a).
Only the preparations with 90% or more viable cells were used
for subsequent experiments. Cells were seeded onto culture plates
precoated with collagen. Cell density was 2× 105 cells/well for 24
well plates and 1× 106 cells/well for six well plates. The cells were
cultured and maintained in William’s medium E, supplemented
with 0.3 µM insulin, 10% FBS, 0.1, µM dexamethasone and 1%
streptomycin/penicillin at 37◦C, 90% humidity and 5% CO2. All
experiments were performed 24 h after cell attachment allowing
the formation of a monolayer.
Assessment of Hepatocyte Viability
Viability of hepatocytes was determined by the MTT assay.
Briefly, 250 µl of MTT solution (300 mg/ml) was added to the
culture medium (200 µl in each well) 1 h before the end of
12 h treatment and incubated at 37◦C for 30 min. After that,
supernatants were discarded and 200µl of DMSO was added and
mixed thoroughly to dissolve the crystals. Then, absorbance was
taken at 570 and 630 nm.
RNA Extraction and Reverse Transcriptase PCR
(RT-PCR)
RNA was extracted from the liver and kidney tissue of all
four groups of mice using the TRIzol reagent, following the
manufacturer’s protocol (Invitrogen, Carlsbad, CA, USA). The
amount of RNA was estimated spectrophotometrically using
nanodrop, HellmaTrayCell Type 105.810 (Hellma Analytical).
Two microgram of extracted RNA from each sample was
converted to cDNA using Thermo Scientific Verso cDNA
synthesis kit (Thermo Scientific, USA). Thermal cycling was
performed following the sequences: 95◦C for 5 min (initial
denaturation) followed by the 35 set of cycles: 95◦C for 30 s
(denaturation), 55◦C for 30 s (primer annealing), and 72◦C for
45 s (primer extension). After the cycles the time for DNA
extension was given 5 min at 72◦C. After the extension, PCR
amplification products were then held at 4◦C and subjected to
electrophoresis on 1.5% agarose gel.
Histological Studies
Portions of livers and kidneys were fixed in 10% v/v neutral
buffered formalin solutions for 24 h. Standard techniques
were followed for processing the tissue and preparation of
paraffin blocks. Fibrosis and necroinflammation were evaluated
in sections (5 µm thick) stained with Masson’s trichrome and
hematoxylin–eosin, respectively, using the Ishak-modified HAI
system (Mannan et al., 2014). Mean values were calculated from
each of six glomeruli per section.
Statistical Analysis
All experimental values have been represented as mean ± S.E.M
(n = 6). Data on biochemical investigation were analyzed
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using analysis of variance (ANOVA) and the group means were
compared by Tukey Test. P-values of 0.05 or less were considered
significant.
RESULTS AND DISCUSSION
A number of naturally occurring agents have been studied to
assess their hepato-protective roles. In many cases TAA has been
used to create a model of hepato-toxicity. These agents include
reynosin (Lim et al., 2013), Ginkgo biloba leaves extract (Al-
Attar, 2012) and ethanolic and aqueous extracts of Phyllanthus
acidus (L.) Skeels (P. Acidus; Jain and Singhai, 2011), etc. An
imidazolium salt, 1,3-diisopropylimidazolium tetrafluoroborate
(DPIM) has also been shown to reduce TAA-induced mouse liver
injury (Ding and Zhuo, 2013). Apart from these agents, SMN
itself has been shown to possess a remarkable protective effect
toward liver as well as other organs. But how SMN exerts its
effects are not fully clear especially in case of cellular signaling
processes.
In the present study, we investigated whether the acute
hepatotoxic and associated nephrotoxic effect of TAA could be
prevented or cured by SMN and if yes what molecular pathways
SMN uses.
Body Weight and Cellular Leakage
Figure 2A shows how SMN increases the survival percentage
of TAA exposed animals. Figure 2B shows that TAA exposure
significantly reduced the body weight of the experimental
animals. SMN, however, could protect mice from this TAA
induced weight loss.
Table 1 demonstrates significant elevation of serum ALP, ALT,
AST, and LDH activities in the livers and BUN and creatinine
levels in the kidneys (Table 2) of the animals exposed to TAA
that altered the transport function and membrane permeability
of respective organs. Leakage of these enzymes was elevated
significantly compared to normal animals upon TAA exposure
indicating severe tissue damage. However, the activities of these
markers in SMN treated group remained almost the same
as normal values. Albumin level was also decreased in TAA
exposed group. SMN post-treatment decreased these alleviated
values of the hepatic and renal markers toward the normal
value.
Nitric oxide level was also increased significantly in
TAA exposed animals. This increased NO production
due to the oxidative stress caused by TAA exposure,
in turn, might induce cell death when NO interacts
with superoxide anion to form peroxynitrite. However,
SMN post-treatment effectively lowers NO production
(Table 1).
Measurement of lipid peroxidation, a biomarker of oxidative
stress, gives a quantitative estimation of ROS mediated cellular
injury. SMN treatment significantly inhibited hepatic and renal
lipid peroxidation compared to TAA exposed animals (Tables 3
and 4).
Effect on Ferric Reducing Antioxidant
Power (FRAP)
Ferric reducing antioxidant power assay gives an indication
of the antioxidant capacity (Benzie and Strain, 1999). In the
present study, we performed FRAP assay to evaluate the
antioxidant capacities of the hepatic as well as renal tissues
of different groups. Results showed TAA exposure caused a
significant reduction in FRAP value. However, SMN treatment
brought the FRAP value back toward normal (Tables 1
and 4).
Effect on Cellular GSH and GSSG Levels
Glutathione, a cysteine-containing tri-peptide, is synthesized
within the cells from its constituent amino acids and plays a
crucial role in maintaining cellular antioxidant capacity. Both the
hepatic and renal GSH level decreased in TAA exposed group
resulting in the decrease in the GSH/GSSG ratio significantly
compared to normal. SMN treatment, however, effectively
elevated the level of GSH toward its normal value. In SMN group,
the GSH level remained almost the same as normal (Tables 3
and 4).
Effect on Cellular Antioxidant Enzymes
We have measured the cellular antioxidant enzymes (CAT, SOD,
GPx, GR, and GST) believed to fight oxidative stress directly.
Results showed the least antioxidant enzyme activities in the
FIGURE 2 | (A) Survival curve of the animals obtained from the data of the 8 weeks study. (B) Effect of silymarin treatment on the body weight of animals of different
groups.
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TABLE 1 | Effect of TAA and SMN on liver marker enzymes.
Parameters Cont SMN TAA TAA+SMN
ALP 14.45 ± 1.25 16.36 ± 1.31 39.12 ± 2.64a 18.35 ± 1.51b
ALT 58.67 ± 1.51 69.23 ± 1.67 140.04 ± 2.31a 81.75 ± 2.11b
AST 132.78 ± 4.15 145.65 ± 5.43 361.73 ± 7.75a 213.47 ± 7.91b
LDH 172.35 ± 5.35 194.63 ± 6.19 510.74 ± 9.68a 247.65 ± 7.27b
Albumin 3.42 ± 0.06 3.31 ± 0.07 2.12 ± 0.10a 2.97 ± 0.09b
NO production 28.05 ± 0.76 29.03 ± 0.81 71 ± 1.78a 38 ± 1.13b
FRAP 100 ± 8,91 100 ± 13.67 100 ± 67.37a 100 ± 17.25b
a“a” values differs significantly from normal control (pa < 0.05); b“b” values differs significantly from toxin control (pb < 0.05). Values are expressed as mean ± SEM, for
six animals in each group.
TABLE 2 | Effect of TAA and SMN on renal markers.
Parameters Cont SMN TAA TAA+SMN
Creatinine (mg/dl) 0.56 ± 0.01 0.58 ± 0.01 1.79 ± 0.036a 0.79 ± 0.031b
BUN (mg/dl) 19.12 ± 0.35 20.13 ± 0.36 36.46 ± 0.69a 23.03 ± 0.39b
TABLE 3 | Effect of TAA and SMN on antioxidant enzymes activities in liver tissue.
Parameters Cont SMN TAA TAA+SMN
SOD 164.59 ± 2.73 165.59 ± 3.51 115.25 ± 4.37a 144.60 ± 3.29b
CAT 154.54 ± 3.03 156.51 ± 3.02 87.45 ± 3.39a 129.14 ± 2.68b
GPx 84.93 ± 1.25 86.23 ± 1.88 48.61 ± 2.13a 75.73 ± 1.77b
GR 40.46 ± 0.74 40.15 ± 0.98 18.99 ± 1.52a 28.14 ± 1.41b
GST 3.05 ± 0.05 2.84 ± 0.06 1.37 ± 0.08a 2.56 ± 0.07b
MDA 2.59 ± 0.05 2.57 ± 0.06 5.34 ± 0.15a 3.13 ± 0.16b
Redox ratio 9.11 ± 0.37 8.98 ± 0.38 4.46 ± 0.23a 7.36 ± 0.26b
a“a” values differs significantly from normal control (pa < 0.05); b“b” values differs significantly from toxin control (pb < 0.05). Values are expressed as mean ± SEM, for
six animals in each group.
TABLE 4 | Effect of TAA and SMN on antioxidant enzymes activities in kidney tissue.
Parameters Cont SMN TAA TAA+SMN
SOD 175.45 ± 5.69 170.37 ± 5.47 129.34 ± 6.71a 161.37 ± 7.36b
CAT 132..56 ± 4.61 133.61 ± 4.54 76.32 ± 4.03a 117.59 ± 5.71b
GPx 125.91 ± 6.13 122.03 ± 5.51 69.23 ± 4.81a 108.15 ± 5.13b
GR 115.35 ± 4.12 109.68 ± 4.05 67.36 ± 3.79a 98.26 ± 4.21b
GST 3.09 ± 0.06 2.98 ± 0.07 1.99 ± 0.08a 2.65 ± 0.09b
MDA 2.51 ± 0.1 2.67 ± 0.14 6.31 ± 0.41a 3.21 ± 0.47b
GSH 25.08 ± 1.07 26.13 ± 1.09 18.32 ± 0.87a 22.04 ± 0.97b
Redox ratio 32.23 ± 1.25 32.06 ± 1.31 21.13 ± 1.41a 28.38 ± 1.46b
FRAP 100 ± 4.53 98.65 ± 4.32 47.25 ± 5.13a 89.05 ± 9.33b
a“a” values differs significantly from normal control (pa < 0.05); b“b” values differs significantly from toxin control (pb < 0.05). Values are expressed as mean ± SEM, for
six animals in each group.
TAA group both in case of hepatic and renal tissues (Tables 3
and 4). SMN post-treatment restored those enzyme activities
toward the normal value. In the SMN group those values were
almost comparable to normal.
The results from the studies performed so far, indicate that
TAA administration caused significant amount of oxidative
stress in liver and also in kidney. Literature (Natarajan
et al., 2006a,b; Amirtharaj et al., 2016) also supports our
indication.
But how SMN ameliorates oxidative stress remained unclear.
Some earlier reports (Abdel-Moneim et al., 2015) indicated
that it could be due to its free radical scavenging capacity. So,
we have investigated its different radical-scavenging (hydroxyl,
superoxide, and nitric oxide radical) properties in a cell-free
system.
The results showed the radical-scavenging properties of SMN
itself as evidenced from its hydroxyl, superoxide and nitric oxide
radical scavenging ability in a cell-free system.
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FIGURE 3 | (A) Superoxide radical (O2−), hydroxyl radical (OH•), and nitric oxide (NO•) scavenging activity of SMN in the cell-free system. Each point represents the
mean ± SEM, n = 6; (B) Collagen content of liver from various groups of animals.
In short, our experiments indicate that SMN treatment gives
protection against the elevation in the level of ROS production
as well as NO production in liver and kidney. However, the
beneficial effects of SMN may arise partly from its radical
scavenging action (Figure 3A).
Collagen Content
The results of our study showed a significant increase in hepatic
and renal collagen content as a result of TAA exposure twice
weekly for 8 weeks. SMN treatment, however, decreased the
collagen content in liver and kidney, though this effect was not
significant in case of kidney (data not shown).
Together all of these results imply that SMN protected mouse
liver and kidney against TAA induced pathophysiology mainly by
exerting its antioxidant properties (Figure 3B).
TAA-Induced Hepatocellular Apoptosis
Then, we wanted to know the mode of cell death. So, we have
done DNA gel electrophoresis to investigate the nature of cell
death (necrosis and/or apoptosis). Results showed that DNA
isolated from TAA-exposed mice produced ladder (a hallmark
of apoptosis) on the agarose gel. Results suggest the anti-
apoptotic nature of SMN against TAA-induced hepatic and renal
pathophysiology (Figures 4A,B).
Histopathological Findings
Histopathological studies of the sections from mouse liver
exposed to TAA showed (in HE staining) severe tissue damage
and vacuolar degeneration. SMN post-treatment attenuated the
hepatic injury and showed significant protection of the hepatic
cells from apoptotic death. There were no such alterations in
SMN group compared to normal (Figure 5A).
Likewise, in case of kidney samples, TAA administration also
showed impaired renal morphology including severe tubular
epithelial cell death associated with inflammatory cell infiltration
and glomerular congestion. SMN post-treatment effectively
protected the kidney tissue from these alterations. Only SMN,
FIGURE 4 | (A) DNA [isolated from liver (A) and kidney (B)] fragmentation
pattern on agarose/EtBr gel. Lane 1 marker (1 kb DNA ladder), lanes 2, 3, 4,
and 5 DNA isolated from normal, SMN treated, TAA administered, SMN
post-treated mice, respectively. Arrows indicate ladder formation. SMN
decreased all the TAA-induced pro-apoptotic events in hepatic and renal
tissue.
however, did not show any significant change compared to
normal (Figure 5B).
In Masson’s Trichrome stains, collagen was found to be
deposited only in the liver blood vessels in the control
and SMN groups. But TAA administration caused a marked
increase in collagen accumulation primarily in the periportal
regions. However, SMN post-treatment for 8 weeks ameliorated
this collagen deposition both in the liver and kidney tissues
(Figures 5C,D).
TAA Stimulated Pro-apoptotic Signaling
via the Activation of JNK: Protective Role
of SMN
The literature suggests that ROS, produced by the administration
of various hepatotoxic agents, can activate JNK (Das et al., 2010;
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FIGURE 5 | Histological observations. Hematoxylin and eosin staining of liver (A) and kidney (B). Cont: normal tissues (10×); TAA: TAA exposed (100 mg/kg
body weight for 56 days) tissues (10×); SMN: SMN treated (150 mg/kg body weight for 56 days) tissues (10×); TAA + SMN: tissues from animals treated with SMN
(150 mg/kg body weight in olive oil orally for 8 weeks) after TAA administration twice a week for 56 days (10×). Masson’s Trichrome staining of liver (C) and kidney
(D). Cont: normal tissues (10×); TAA: TAA exposed (100 mg/kg body weight for 56 days) tissues (10×); SMN: SMN treated (150 mg/kg body weight for 56 days)
tissues (10×); TAA + SMN: tissues from animals treated with SMN (150 mg/kg body weight in olive oil orally for 8 weeks) after TAA administration twice a week for
56 days (10×).
Du et al., 2014; Pal et al., 2015a). So, we first checked the level
of JNK. Our result showed elevated level of JNK in TAA group.
Two pathways may activate JNK. One of them involves oxidation
of kinase inhibitors sequestering JNK or upstream molecules like
ASK1. Alternatively, sustained JNK activation can be the result
of inactivation of JNK phosphatases by ROS. Then, we wanted
to check whether SMN could inhibit the phosphorylation and
thereby activation of JNK as previous results showed that SMN
treatment effectively inhibited JNK activation (Kim et al., 2016).
JNK activation might be a potential regulator of mitochondrial
permeabilization (Ghosh et al., 2010; Zhao et al., 2014).
Phosphorylated JNK in turn phophorylates Bcl-2 family proteins
such as Bcl-2 and Bcl-xL (Ma et al., 2014; Kim et al., 2015). Active
Bcl-2 (unphosphorylated) maintains the balance between pro
and anti-apoptotic proteins. So, once it is phosphorylated, that
balance is lost and mitochondrial membrane depolarises resulting
in pore formation starts ultimately leading to apoptosis. The
result of our study showed that SMN post-treatment prevented
the phosphorylation of Bcl-2 and resulting apoptosis (Figure 6).
The Role of PI3K-Akt Cell Survival
Pathway
The PI3K-Akt Pathway is a signaling pathway that regulates
cell survival and growth in response to extracellular signals.
Literature suggests that the PI 3-kinase/Akt signaling pathway
plays an important role in cell survival in liver (Jiang et al., 2014;
Rawat and Bouchard, 2015; Saha et al., 2016).
Recent report (Hawkins and Stephens, 2016) also suggest
that class 1 PI3Ks, composed of a regulatory subunit p85
and a catalytic subunit p110, is stimulated by activated
receptor tyrosine kinase (RTK). RTKs are activated by the
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FIGURE 6 | Continued
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FIGURE 6 | Continued
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FIGURE 6 | Western blot analysis of different proteins. β-actin served as a loading control. “a” indicates the significant difference between the normal and
TAA-exposed animals liver and kidney tissue homogenates, “b” indicates the significant difference between TAA and SMN+TAA-treated animal tissue homogenates.
Each column represents mean ± SEM, n = 6 (pa < 0.05, pb < 0.05).
binding of an extracellular ligand (SMN here) in the plasma
membrane. p85 subunit then binds to phosphorylated tyrosine
residues on the activated receptor via its SH2 domain and
recruits the p110 forming the fully active PI3K enzyme.
Activated PI3K phosphorylates phosphoinositides and forms
phosphatidylinositol 3,4,5-triphosphate (PIP3) which facilitates
the recruitment of Akt to the plasma membrane. Akt is
phosphorylated by phosphoinositide-dependent kinase-1
(PDK1) at Thr308. Full activation of Akt, however, needs
phosphorylation at Ser473 as well, by different other proteins
like PDK-2, mTORC, etc., activated Akt then phosphorylates
downstream molecules like BAD, caspase-9 and consequently
initiates apoptosis. In this study, both the levels of PI 3-k
and p-Akt levels were reduced in TAA-exposed murine liver
compared with the control animals. These alterations in
these protein levels due to TAA exposure were attenuated by
treatment with SMN because of either increased synthesis or less
degradation of these proteins in the presence of SMN (Figure 6).
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TABLE 5 | The product size and annealing temperature of the primers
used for Fas, Fas L, and actin genes.
Gene Oligonucleotides used for real-time
polymerase chain reaction (PCR)
primer sequence 5′ to 3′
Annealing
temperature
(◦C)
DNA
bases
(bp)
Fas Fp:AGACAGGATGACCCTGAATCTA 54.7 22
Bp:TTCTGCTCAGCTGTGTCTTG 55.1 20
Fas L Fp:ATATGGGCCCACAGCAG 54.9 17
Bp:AGACTCTCATTCAAGACAATATTCC 52.4 25
Actin Fp:ACATTGGCATGGCTTTGTTT 53.8 20
Bp:GTCCTCAGCCACATTTGTAGA 54.5 21
The Extrinsic Apoptotic Pathway in
Hepatocytes
Literature reveals that high amounts of Fas, a member of the
tumor necrosis factor (TNF) receptor superfamily (also known as
CD95), are constitutively expressed on the surface of hepatocytes
(Schneider et al., 1997; Wang et al., 2010). Fas plays a crucial
role in case of many types of liver diseases also. After Fas ligand
(FasL) binds to Fas on the cell surface, two apoptotic pathways
can be initiated, a direct type I pathway and a mitochondria
dependent type II pathway. Type I pathway starts with the
formation of the death inducing signaling complex (DISK) at the
activated Fas receptor. FasL binding initiates a conformational
change. Consequently the intracellular domain of Fas is able
FIGURE 7 | Measurement of the mitochondrial membrane potential by
flow cytometry analysis (using JC-1) from liver tissue homogenates.
to bind to the adaptor FADD which in turn activates caspase
8 in the cytosol from pro-caspase 8. Activated caspase 8 then
proteolytically degrades pro-caspase 3 to form fully active caspase
3 which then initiates downstream signaling ultimately leading to
apoptosis.
To know whether SMN could inhibit the Fas mediated (type I)
apoptosis or not, we investigated the expression of capase 8 (at
FIGURE 8 | Schematic diagram of the TAA induced hepatic as well as renal toxicity and its prevention by SMN.
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the protein level by western blot) and Fas and FasL (at the mRNA
level by RT-PCR) (Table 5). Results showed that both the levels
of Fas/FasL and caspase 8 have been suppressed significantly in
the SMN post-treatment group, i.e., SMN protected TAA exposed
mouse hepatocytes from Fas/FasL and caspase 8 mediated
apoptosis effectively (Figure 6).
PKC and MAPKs Mediated Renal
Apoptosis
Next, we have searched about the involvement of ROS in renal
dysfunction and the signaling pathways associated. Literature
indicated that oxidative stress could induce PKC and MAPKs
mediated renal tissue damage leading to apoptosis (Tuttle et al.,
2005; Xu et al., 2010). So, we measured the above said signaling
molecules quantitatively using western blot assay. The results
of our study revealed that TAA exposure indeed increased the
expression of different forms of PKC (PKCα, PKCβ, and PKCε)
and MAPKs (p38 and JNK). SMN treatment, however, restored
their levels toward the normal value and protected the kidney
(Figure 6).
Apoptotic Cell Death Pathway both in
Case of Liver and Kidney
Finally, we have investigated the intrinsic apoptotic cell death
pathway in liver and renal tissues as TAA exposure might turn
on this pathway. Apoptosis is one of the most complex fate of
a cell primarily depends on the balance between pro-apoptotic
and anti-apoptotic proteins. Apoptosis occurs when this balance
is compromised either by the up-regulation of pro-apoptotic
proteins and/or down regulation of anti-apoptotic proteins (Hui
et al., 2016). The results of our study reveal that TAA increased
the expressions of pro-apoptotic proteins, such as Bad and Bax
and decreased the expressions of anti-apoptotic proteins Bcl-2
and Bcl-xL. Our results also showed that SMN post-treatment
effectively ameliorated all of these anomalies.
In normal, healthy cells, pro-apoptotic protein Bax is present
in the cytosol. When apoptotic signal is present, Bax undergoes a
conformational change and translocated into the mitochondria
and causes damages to the outer mitochondrial membrane
causing pores on the mitochondrial outer membrane leading
to mitochondrial membrane depolarisation (Gross et al., 1998;
Bhattacharyya et al., 2014).
But maintenance of mitochondrial membrane potential (ψm)
is crucial for cellular survival as its (ψm) loss induces the release
of cytochrome c into the cytosol and activates downstream
apoptotic signaling pathways (Sinha et al., 2013). Results of
our present study showed that TAA exposure decreased the
mitochondrial membrane potential (in hepatocytes) significantly
and SMN could ameliorate this phenomenon effectively
(Figure 7). Immunoblot studies also showed that cytosolic
cytochrome c level was increased in TAA exposed group
compared to normal. SMN post-treatment also protected mice
liver and kidney from mitochondrial depolarisation directed
cytochrome c release in the cytosol (Figure 6).
After the release into the cytosol, cytochrome c forms
apoptosomes that activates caspase 9 and other downstream
caspases (Eleftheriadis et al., 2016). In the present study,
apoptosis was determined by the estimation of caspase-3
activation and PARP cleavage. Caspase 9 cleaves pro-caspase 3
and forms activated cleaved caspase 3, indicator of caspase-3
activation, which in turn, cleaves PARP and induces subsequent
apoptosis (Pal et al., 2015b). Se, we measured the levels of cleaved
caspase 3 and PARP. Both of these levels were significantly
increased in TAA exposed liver and kidney tissues compared
to normal animals. However, normalcy was restored in SMN
post-treated group in both the cases. It is worth-mentioning that
only SMN was not responsible for either caspase 3 activation
or PARP-cleavage as evident from the results of SMN group
(Figure 6).
CONCLUSION
In summary, our study indicates that TAA generates oxidative
stress that leads to systematic apoptosis within the liver (via the
activation of JNK) and kidney (via PKC and MAPKs mediated
molecular signaling pathways). SMN, a well-known antioxidant,
might protect those organs by elevating the antioxidant enzyme
activities and scavenging ROS as evidenced from biochemical
results. Moreover SMN induces PI3K-Akt cell survival pathway
in the liver and prevents apoptosis in both the organs (Figure 8).
So, we are hopeful about the beneficial role of SMN in
ameliorating liver as well as kidney under pathophysiologic
conditions.
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